Relative efficacy of intracameral moxifloxacin injection methods

J Cataract Refract Surg. 2023 May 1;49(5):538-542. doi: 10.1097/j.jcrs.0000000000001151.

Abstract

Purpose: To determine the amount of moxifloxacin remaining in the anterior chamber (AC), immediately after its injection using 3 current injection methods, assuming mixing and fluid exchange with the AC contents during injection of the drug, and to determine the most desirable injection method.

Setting: Department of Ophthalmology and Vision Sciences and Institute of Biomedical Engineering, University of Toronto, Toronto, Canada.

Design: Mathematical modeling.

Methods: Mathematical modeling using first-order mixing methods were used to assess mixing.

Results: The Kaiser method of injecting 0.5 mL × 100 μg/0.1 mL does not achieve the desired 500 μg level of moxifloxacin in the AC. The "straight from the bottle" method of injecting 0.1 mL × 500 μg/0.1 mL is fraught with potential error, yielding a relatively unreliable final amount in the AC. Injecting 0.5 to 0.6 mL × 150 μg/0.1 mL yields a result closest to the desired goal.

Conclusions: Based on the calculation, the most accurate of current methods to deliver 500 μg moxifloxacin intracamerally is the method of 150 μg/0.1 mL × 0.5 to 0.6 mL.

MeSH terms

  • Anterior Chamber
  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / therapeutic use
  • Endophthalmitis* / drug therapy
  • Endophthalmitis* / prevention & control
  • Fluoroquinolones
  • Humans
  • Injections
  • Moxifloxacin / administration & dosage
  • Moxifloxacin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Moxifloxacin